Nantong Tumor Hospital Branch North

Nantong, Jiangsu 226000

0 studies enrolling now · 2 studies all time

What they study most

Esophageal Squamous Cell Carcinoma (ESCC), Metastatic Non-small Cell Lung Cancer, Non-small Cell Lung Cancer

Studies at this site

• A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer — Running, not enrolling
• A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma — Completed